Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis

Annals of the Rheumatic Diseases
Anastasia PapadopoulouEvangelia Yannaki

Abstract

The role of mesenchymal stem cells (MSC) in experimental arthritis is undoubtedly conflicting. This study explored the effect of bone marrow-derived MSC in previously untested and pathogenetically different models of rheumatoid arthritis (RA). MSC were tested both in an induced (adjuvant-induced) and a spontaneous (K/BxN) arthritis model. Arthritis was assessed clinically and histologically. The proliferation of splenocytes and fibroblast-like synoviocytes (FLS) in the presence of MSC was measured by radioactivity incorporation. Toll-like receptor (TLR) expression was measured by real-time PCR. T-regulatory cell (Treg) frequency, T-cell apoptosis and cytokine secretion were monitored by flow cytometry. MSC, in vitro, strongly inhibited critical cell populations; splenocytes and FLS. In contrast, MSC proved ineffective in vivo, unless they were administered before disease onset, an effect implying that the inflammatory arthritic milieu potentially abrogates MSC immunomodulatory properties. In order to alleviate inflammation before MSC infusion, the authors administered, at arthritis onset, a short course with a proteasome inhibitor, bortezomib, whereas MSC were infused when established disease was expected. The bortezomib plus M...Continue Reading

Citations

Aug 29, 2014·Stem Cell Research & Therapy·Catherine B SullivanJosephine Mary Murphy
Sep 12, 2015·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Jaroslav DenkovskijGailute Kirdaite
Jun 16, 2015·Immunology Letters·Wei CaoYufang Shi
Aug 10, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yi ZhangYanyun Zhang
Jun 13, 2015·Stem Cells and Development·Hafsa Munir, Helen M McGettrick
Mar 24, 2015·Bioscience Reports·Imran UllahGyu Jin Rho
Feb 19, 2014·Human Vaccines & Immunotherapeutics·Gary ReynoldsCatharien M U Hilkens
May 12, 2015·Journal of Immunology Research·Marta E Castro-Manrreza, Juan J Montesinos
Nov 9, 2016·Stem Cells International·Arman SaparovWilliam C W Chen
Apr 27, 2017·International Journal of Molecular Sciences·Stella CosenzaDanièle Noël
May 19, 2017·Cellular Reprogramming·Ourania Trohatou, Maria G Roubelakis
Jun 27, 2017·American Journal of Veterinary Research·Jacqueline A HillLisa A Fortier
Aug 20, 2017·Cell and Tissue Banking·Andreas Nicodemou, Lubos Danisovic
Nov 28, 2017·Stem Cells Translational Medicine·Ming ShiFu-Sheng Wang
Nov 6, 2018·Annals of the Rheumatic Diseases·Chijioke H Mosanya, John D Isaacs
Jun 4, 2015·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Nianlan YangXing-Ming Shi
Mar 25, 2017·International Immunology·Vito Pistoia, Lizzia Raffaghello

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.